Adenia Partners Makes First Majority Investment in Egypt
Adenia Partners (“Adenia”), a leading private equity firm focused on growth opportunities in Africa, has signed definitive agreements to acquire a majority stake in Parkville...
Category : Clinical Research, Pharma & Healthcare Financing
J. Craig Venter Launches Diploid Genomics, Advancing Human Genomics
Healthier Capital, a leading health-tech venture capital firm, joins as a co-founder and sole external investor in seed round Diploid Genomics, Inc. (DGI), an AI-driven...
Azafaros to Present Nizubaglustat Research at WORLDSymposium 2026
Azafaros, a company building a portfolio to become a leader in lysosomal storage disorders with the goal of addressing neurological symptoms, today announced that its...
Daiichi Sankyo Names New Head of Translational Research Europe
Daiichi Sankyo (TSE:4568) has appointed Veronika Rozehnal, Ph.D., to succeed Jürgen Müller, Ph.D., as the Head of the Translational Research Center Europe. Dr. Jürgen Müller...
Agendia MammaPrint Guides Anthracycline Use in Early Breast Cancer
Update based on real-world evidence from the FLEX Study presented at the 2025 San Antonio Breast Cancer Symposium Agendia, Inc., a leader in precision oncology...
D3 Bio Gets FDA Clearance for Two IND Trials in KRAS Cancers
D3 Bio, a global clinical‑stage biotechnology company focused on developing transformative oncology therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has cleared...
InterAx & Alveus Partner on Metabolic Disease Therapy
InterAx Biotech Ltd (“InterAx”) and Alveus Therapeutics Inc. (“Alveus”) today announced a strategic research collaboration and licensing agreement to develop a differentiated small molecule candidate...
Agno Pharma Acquires Actylis CDMO Manufacturing Asset
Agno Pharma, a global contract development and manufacturing organization (CDMO) specializing in small-molecule active pharmaceutical ingredients (APIs) and critical GMP intermediates announced the acquisition of...
Alta Semper Secures $57.5M from EIB & IFC to Expand Africa Care
Alta Semper Capital LLP (“Alta Semper”), a London-based private equity firm focused on healthcare and consumer investments in high-growth markets, today announced that it has...
Almirall Highlights R&D Pipeline & Leadership in Dermatology
Almirall, S.A. (ALM), a global pharmaceutical company dedicated to medical dermatology, is participating in the 44th J.P. Morgan Healthcare Conference 2026, taking place from 12th to 14th January...
Asimov and AGC Biologics Launch Simplified Viral Vector Production
Asimov’s LV Edge Packaging cell line routinely achieves high titers for therapeutic transgenes and is now available at AGC Biologics’ Cell and Gene Center of...
Owkin Advances Biological AI Super Intelligence with NVIDIA
Collaboration Leverages NVIDIA’s Open Models, AI Infrastructure and Expertise to Build Next-Generation Biological Reasoning Models for Drug Development Owkin, an AI company on a mission...
Cytotheryx Secures $60M Series A, Confirms Debt to Expand Facilities
Cytotheryx’s Series A financing, alongside strategic debt funding, will advance its cell therapy programs toward clinical development and support GMP manufacturing scale-up. Cytotheryx, Inc. , a...
WindRose Health Invests in Avalon Healthcare Solutions
WindRose Health Investors, LLC (“WindRose”), the New York-based healthcare private equity firm, announced that it has completed an investment in Avalon Healthcare Solutions (“Avalon” or...
Foresee Pharma Signs Global License Deal for MMP-12 Inhibitors
Foresee Pharmaceuticals (TPEx: 6576), (“Foresee”) today announced, following approval at its 2025 Extraordinary General Shareholders’ Meeting, that Foresee Pharmaceuticals USA Inc., the Company’s fully-owned US...